Mapping ERC frontier research on CRISPR/Cas gene-editing
A new ERC report explores the transformative potential of CRISPR/Cas technology, analysing 1,297 ERC-funded projects. Of these, 86% advance basic research into biological mechanisms and human diseases, while 14% target applications in agriculture, biotechnology, and medicine.